(Q46178941)

20 December 2017

title

Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE. (English)

1 reference

20 December 2017

author

Brian Werth

1

1 reference

20 December 2017

Katie E Barber

object named as

Katie E Barber

2

0 references

Michael J Rybak

7

object named as

Michael J Rybak

1 reference

20 December 2017

author name string

Kieu-Nhi T Tran

3

1 reference

20 December 2017

P Nonejuie

4

1 reference

20 December 2017

G Sakoulas

5

1 reference

20 December 2017

J Pogliano

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

9 October 2014

1 reference

20 December 2017

Journal of Antimicrobial Chemotherapy

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

70

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

489-493

1 reference

20 December 2017

Management of multidrug-resistant enterococcal infections

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

A vital stain for studying membrane dynamics in bacteria: a novel mechanism controlling septation during Bacillus subtilis sporulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

Role of class A penicillin-binding proteins in PBP5-mediated beta-lactam resistance in Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU386

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU386

1 reference

20 December 2017

PubMed ID

25304643

1 reference

20 December 2017